Keywords: tap, holdings, file, spectracef, nda, presents, new

TAP Holdings to file Spectracef NDA, presents new data

Article | 11 October 1999

TAP Holdings presented data from two Phase III clinical trials of itsantibiotic Spectracef (cefditoren pivoxil) at the 39th Intersciences Conference ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abbott

Abbott Laboratories

Go to company listing

Related Drugs

Cefditoren Pivoxil

Spectracef

Go to drug listing